Aktie des Tages mit Allzeithoch - Alexion Pharmaceuticals, Inc. (ALXN) - Soliris Medikament laesst Gewinne Sprudeln
http://t.co/dlH2qssL
From:tradingeco: at: Fri, 10 Feb 2012 10:39:42 +0000
RT @BioWorld: $ALXN up 5% today after company reports solid 2011 Y-E financials, growing Soliris sales; analysts bullish on ’12 prospects
From:mariempowers: at: Thu, 09 Feb 2012 22:11:43 +0000
RT @fischmd: The most expensive drug is...Soliris ($409,500/yr),
for paroxysmal nocturnal hemoglobinuria (PNH). via@harrygreenspun, http://t.co/o5BvGrQS
From:MikeOinSATX: at: Thu, 09 Feb 2012 21:59:41 +0000
$ALXN up 5% today after company reports solid 2011 Y-E financials, growing Soliris sales; analysts bullish on ’12 prospects
From:BioWorld: at: Thu, 09 Feb 2012 20:26:02 +0000
Soliris Drives Double-Digit Growth for Alexion in 4Q, but Shares Still Look Overvalued: http://t.co/W8AVBmOw
PatientsVille.com
does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be
used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.We hope you found our information about Soliris.